TY - JOUR
T1 - Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds
AU - Wamhoff, Eike Christian
AU - Ronsard, Larance
AU - Feldman, Jared
AU - Knappe, Grant A.
AU - Hauser, Blake M.
AU - Romanov, Anna
AU - Case, James Brett
AU - Sanapala, Shilpa
AU - Lam, Evan C.
AU - Denis, Kerri J.St
AU - Boucau, Julie
AU - Barczak, Amy K.
AU - Balazs, Alejandro B.
AU - Diamond, Michael S.
AU - Schmidt, Aaron G.
AU - Lingwood, Daniel
AU - Bathe, Mark
N1 - Publisher Copyright:
© 2024, The Author(s).
PY - 2024/12
Y1 - 2024/12
N2 - Protein-based virus-like particles (P-VLPs) are commonly used to spatially organize antigens and enhance humoral immunity through multivalent antigen display. However, P-VLPs are thymus-dependent antigens that are themselves immunogenic and can induce B cell responses that may neutralize the platform. Here, we investigate thymus-independent DNA origami as an alternative material for multivalent antigen display using the receptor binding domain (RBD) of the SARS-CoV-2 spike protein, the primary target of neutralizing antibody responses. Sequential immunization of mice with DNA-based VLPs (DNA-VLPs) elicits protective neutralizing antibodies to SARS-CoV-2 in a manner that depends on the valency of the antigen displayed and on T cell help. Importantly, the immune sera do not contain boosted, class-switched antibodies against the DNA scaffold, in contrast to P-VLPs that elicit strong B cell memory against both the target antigen and the scaffold. Thus, DNA-VLPs enhance target antigen immunogenicity without generating scaffold-directed immunity and thereby offer an important alternative material for particulate vaccine design.
AB - Protein-based virus-like particles (P-VLPs) are commonly used to spatially organize antigens and enhance humoral immunity through multivalent antigen display. However, P-VLPs are thymus-dependent antigens that are themselves immunogenic and can induce B cell responses that may neutralize the platform. Here, we investigate thymus-independent DNA origami as an alternative material for multivalent antigen display using the receptor binding domain (RBD) of the SARS-CoV-2 spike protein, the primary target of neutralizing antibody responses. Sequential immunization of mice with DNA-based VLPs (DNA-VLPs) elicits protective neutralizing antibodies to SARS-CoV-2 in a manner that depends on the valency of the antigen displayed and on T cell help. Importantly, the immune sera do not contain boosted, class-switched antibodies against the DNA scaffold, in contrast to P-VLPs that elicit strong B cell memory against both the target antigen and the scaffold. Thus, DNA-VLPs enhance target antigen immunogenicity without generating scaffold-directed immunity and thereby offer an important alternative material for particulate vaccine design.
UR - http://www.scopus.com/inward/record.url?scp=85183675567&partnerID=8YFLogxK
U2 - 10.1038/s41467-024-44869-0
DO - 10.1038/s41467-024-44869-0
M3 - Article
C2 - 38291019
AN - SCOPUS:85183675567
SN - 2041-1723
VL - 15
JO - Nature communications
JF - Nature communications
IS - 1
M1 - 795
ER -